Skip to main content
رجوع
AZTA logo

Azenta, Inc.

جودة البيانات: 100%
ذروة بيع
AZTA
NASDAQ Healthcare Medical - Instruments & Supplies
KWD 21.31
▲ KWD 0.86 (4.21%)
القيمة السوقية: 981.57M
نطاق اليوم
KWD 20.10 KWD 21.33
نطاق 52 أسبوعًا
KWD 19.94 KWD 41.73
حجم التداول
839,025
متوسط 50 يوم / 200 يوم
KWD 30.65 / KWD 31.45
الإغلاق السابق
KWD 20.45

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -17.6 0.4
P/B 0.6 2.9
ROE % -3.2 3.9
Net Margin % -9.4 3.8
Rev Growth 5Y % 3.7 10.0
D/E 0.1 0.2

السعر المستهدف للمحللين

Hold
KWD 43.000 +101.8%
Low: KWD 38.000 High: KWD 45.000
مكرر الربحية المستقبلي
26.0
ربحية السهم المستقبلية
KWD 0.788
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
620 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 1.760
KWD 1.730 – KWD 1.802
740 M 1
FY2029 KWD 1.300
KWD 1.278 – KWD 1.331
680 M 1
FY2028 KWD 1.294
KWD 1.048 – KWD 1.470
700 M 4

النقاط الرئيسية

Revenue grew 3.69% annually over 5 years — modest growth
Debt/Equity of 0.06 — conservative balance sheet
Generating 38.32M in free cash flow
PEG of 0.39 suggests growth is underpriced
Capital efficient — spends only 5.70% of revenue on capex

النمو

Revenue Growth (5Y)
3.69%
Revenue (1Y)3.55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-3.19%
ROIC-0.46%
Net Margin-9.39%
Op. Margin-1.90%

الأمان

Debt / Equity
0.06
Current Ratio2.98
Interest Coverage0.00

التقييم

P/E Ratio
-17.60
P/B Ratio0.57
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 3.55% Revenue Growth (3Y) -5.51%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 3.69% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 593.82M Net Income (TTM) -55.76M
ROE -3.19% ROA -2.71%
Gross Margin 45.52% Operating Margin -1.90%
Net Margin -9.39% Free Cash Flow (TTM) 38.32M
ROIC -0.46% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.06 Current Ratio 2.98
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -17.60 P/B Ratio 0.57
P/S Ratio 1.65 PEG Ratio 0.39
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 981.57M Enterprise Value 812.96M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 593.82M 573.45M 665.07M 555.50M 513.70M
Net Income -55.76M -164.90M -14.26M -428.96M 110.75M
EPS (Diluted) -1.22 -3.09 -0.22 -0.15 -0.39
Gross Profit 270.28M 254.62M 233.26M 230.62M 214.51M
Operating Income -11.27M -29.98M -82.20M -24.02M 3.60M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.06B 2.10B 2.89B 3.72B 1.82B
Total Liabilities 330.70M 331.07M 351.22M 352.74M 494.18M
Shareholders' Equity 1.73B 1.77B 2.53B 3.36B 1.33B
Total Debt 111.17M 70.68M 60.44M 49.23M 94.77M
Cash & Equivalents 279.78M 310.93M 678.91M 658.27M 227.43M
Current Assets 708.34M 832.81M 1.42B 2.46B 777.37M
Current Liabilities 237.67M 204.84M 210.93M 230.55M 345.09M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#494 of 827
37

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026